跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 755 条关于
“CRAF”
全部
755
临床试验
566
药物
61
机构
4
资讯
124
去年
Servier and Black Diamond Therapeutics Forge $780M Global Licensing Deal for Novel RAF/RAS Cancer Therapy
去年
Verastem Oncology Completes FDA Submission for Avutometinib Plus Defactinib in Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
去年
Verastem Oncology Refinances Debt and Advances Avutometinib/Defactinib Combination
去年
Verastem Oncology's RAMP 203 Trial Shows Encouraging Initial Data for Triplet Combination in Advanced KRAS G12C Mutant NSCLC
去年
Verastem's Avutometinib and Defactinib Combination Receives FDA Priority Review for Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
2年前
Verastem Oncology's Avutometinib and Defactinib Combination Receives FDA Priority Review for Recurrent KRAS Mutant LGSOC
去年
Verastem Oncology Seeks FDA Approval for Avutometinib and Defactinib Combination in Recurrent KRAS Mutant LGSOC
去年
Verastem Oncology Gears Up for Potential 2025 Launch of Avutometinib Plus Defactinib in KRAS Mutant LGSOC
2年前
Plexium Advances First-in-Class IKZF2 Degrader PLX-4545 into Phase 1 Clinical Trial
去年
FDA Reviewing Avutometinib Plus Defactinib for Recurrent KRAS-Mutant Low-Grade Serous Ovarian Cancer
第 1 页,共 13 页
上一页
下一页